Barinthus Biotherapeutics Plc ADR
(BRNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,223 | 5,321 | 26,484 | 18,263 | 2,574 |
| Depreciation Amortization | 1,221 | 4,323 | 3,146 | 1,958 | 966 |
| Income taxes - deferred | -516 | -4,337 | -2,403 | -1,778 | -863 |
| Accounts receivable | 4,961 | -5,833 | -6,162 | -17,028 | -18,352 |
| Accounts payable and accrued liabilities | -1,707 | 1,140 | 142 | 776 | 1,739 |
| Other Working Capital | 8,254 | -5,524 | -2,954 | -22,571 | -13,623 |
| Other Operating Activity | 2,836 | -9,521 | -21,341 | 5,408 | 20,980 |
| Operating Cash Flow | $-3,174 | $-14,431 | $-3,088 | $-14,972 | $-6,579 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,507 | -5,750 | -5,164 | -3,146 | -1,092 |
| Investing Cash Flow | $-2,507 | $-5,750 | $-5,164 | $-3,146 | $-1,092 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -159 | -159 | -159 | -159 |
| Common Stock Issued | 1,789 | 484 | N/A | N/A | N/A |
| Other Financing Activity | -100 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,689 | $325 | $-159 | $-159 | $-159 |
| Exchange Rate Effect | 935 | 187 | -5,539 | -3,450 | -5,628 |
| Beginning Cash Position | 194,385 | 214,054 | 214,054 | 214,054 | 214,054 |
| End Cash Position | 191,328 | 194,385 | 200,104 | 192,327 | 200,596 |
| Net Cash Flow | $-3,057 | $-19,669 | $-13,950 | $-21,727 | $-13,458 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,174 | -14,431 | -3,088 | -14,972 | -6,579 |
| Capital Expenditure | -2,507 | -6,138 | -5,552 | -3,146 | -1,092 |
| Free Cash Flow | -5,681 | -20,569 | -8,640 | -18,118 | -7,671 |